NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases today announced that John W. Hadden II, President & Chief Executive Officer, will present at the upcoming 26th Annual JP Morgan Healthcare Conference in San Francisco, California on Monday, January 7, 2008 at 8:30 a.m. PST. Mr. Hadden will provide an overview of the Company’s product portfolio and business developments.
